Dopamine in the Basal Ganglia Its Role and Therapeutic Implications (Including the Clinical Use of L-DOPA)

British Medical Bulletin

Volumn 29, Issue 2, 1973, Pages 172-178

  Hornykiewicz, Oleh ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; AROMATIC LEVO AMINO ACID DECARBOXYLASE; BUTYROPHENONE DERIVATIVE; DOPA; DOPAMINE; HOMOVANILLIC ACID; METIROSINE; PHENOTHIAZINE DERIVATIVE;

ANIMAL; BASAL GANGLION; BRAIN LEVEL; CORPUS STRIATUM; DRUG EFFECT; HUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SYNAPTIC TRANSMISSION;

AMPHETAMINE; ANIMAL; BASAL GANGLIA; BRAIN CHEMISTRY; BUTYROPHENONES; CORPUS STRIATUM; DIHYDROXYPHENYLALANINE; DOPA DECARBOXYLASE; DOPAMINE; HOMOVANILLIC ACID; HUMAN; METHYLTYROSINES; PARKINSON DISEASE; PHENOTHIAZINES; SYNAPTIC TRANSMISSION;

EID: 0015626895     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a070990     Document Type: Article

References (57)

1. Andén, N. E., Carlsson, A., Dahlström, A., Fuxe, K., Hillarp, N.Å.& Larsson, K. (1964) Life Sci. 3, 523-530.
2. Andén, N. E., Fuxe, K., Hamberger, B. & Hökfelt, T. (1966) Acta physiol, scand. 67, 306-312.
3. Andén, N. E., Roos, B. E. & Werdinius, B. (1964) Life Sci. 3, 149-158.
4. Arbuthnott, G. W., Crow, T. J., Fuxe, K. & Ungerstedt, U. (1970) J. Physiol., Lond. 210, 61P-62P.
5. Barbeau, A.(1969) Can. med. Ass. J. 101, 791-800.
6. Barbeau, A., Sourkes, T. L. & Murphy, G. F. (1962) In: Ajuria- guerra, J. de, ed. Monoamines et système nerveux central, pp. 247-262. Georg, Geneva.
7. Barolin, G. S., Bemheimer, H. & Homykiewicz, O. (1964) Schweizer Arch. Neurol. Psychiat. 94, 241-248.
8. Bartholini, G., Kuruma, I. & Pletscher, A.(1971) Nature, Lond. 230, 533-534 [Letter].
9. Bédard, P., Larochelle, L., Poirier, L. J. & Sourkes, T. L. (1970) Can. J. Physiol. Pharmac. 48, 82-84.
10. Bemheimer, H., Birkmayer, W., Homykiewicz, O., Jellinger, K. & Seitelberger, F. (1965) In: Proc. VIII int. Congr. Neurol., Vol IV, pp. 145-148. Wiener Medizinische Akademie, Vienna.
11. Bemheimer, H. & Homykiewicz, O. (1965) Klin. Wschr. 43, 711-715.
12. Bertler, Å., Hillarp, N.Å.& Rosengren, E. (1960) Acta physiol. scand. 50, 113-118.
13. Bertler,Å.& Rosengren, E. (1959) Experientia, 15, 10-11.
14. Besson, M. J., Cheramy, A., Feltz, P. & Glowinski, J. (1969) Proc. natn. Acad. Sci. U.S.A. 62, 741-748.
15. Bieger, D., Larochelle, L. & Homykiewicz, O. (1972) Eur. J. Pharmac. 18, 128-136.
16. Birkmayer, W. (1970) In: Barbeau, A. & McDowell, F. H., ed. L-DOPA and parkinsonism, pp. 12-16. Davis, Philadelphia, Pa.
17. Birkmayer, W. & Homykiewicz, O. (1961) Wien. klin. Wschr. 73, 787-788.
18. Blaschko, H. (1957) Br. med. Bull. 13, 162-165.
19. Carlsson, A.(1959) Pharmac. Rev. 11, 490-493.
20. Carlsson, A.& Lindqvist, M. (1963) Acta pharmac. tox. 20, 140- 144.
21. Carlsson, A., Lindqvist, M. & Magnusson, T. (1957) Nature, Lond. 180, 1200 [Letter].
22. Connor, J. D. (1970) J. Physiol., Lond. 208, 691-703.
23. Cools, A. R. & Rossum, J. M. van (1970) Archs int. Pharmacodyn. Thér. 187, 163-173.
24. Costa, E. & Neff, N. H. (1966) In: Costa, E., Côté, L. J. & Yahr, M. D., ed. Biochemistry and pharmacology of the basal ganglia, pp. 141-155. Raven Press, Hewlett, N.Y.
25. Cotzias, G. C., Van Woert, M. H. & Schiffer, L. M. (1967) New Engl. J. Med. 276, 374-379.
26. Coyle, J. T. & Snyder, S. H. (1969) Science, N.Y. 166, 899-901.
27. Davidson, L., Lloyd, K., Dankova, J. & Homykiewicz, O. (1971) Experientia, 27, 1048-1049.
28. Ehringer, H. & Homykiewicz, O. (1960) Klin. Wschr. 38, 1236- 1239.
29. Emst, A. M. (1967) Psychopharmacologia, 10, 316-323.
30. Fog, R. L., Randrup, A. & Pakkenberg, H. (1967) Psychopharmacologia, 11, 179-183.
31. Frère, J. M. & Barbeau, Å.(1971) Lancet, 2, 269-270 [Letter].
32. Fuxe, K., Hökfelt, T. & Ungerstedt, U. (1970) Int. Rev. Neurobiol. 13, 93-126.
33. Glowinski, J. & Iversen, L. (1966) Biochem. Pharmac. 15, 977- 987.
34. Goldstein, M., Anagnoste, B., Battista, A. F., Owen, W. S. & Nakatani, S. (1969) J. Neurochem. 16, 645-653.
35. Hökfelt, T. & Ungerstedt, U. (1969) Acta physiol, scand. 76, 415-426.
36. Homykiewicz, O. (1963) Wien. klin. Wschr. 75, 309-312.
37. Homykiewicz, O. (1964) In: Trabucchi, E., Paoletti, R. & Canal, N., ed. Biochemical and neurophysiological correlation of centrally acting drugs, pp. 57-68. Pergamon Press, Oxford.
38. Homykiewicz, O. (1966) Pharmac. Rev. 18, 925-964.
39. Homykiewicz, O. (1971a) In: Biel, J. H. & Abood, L. G., ed. Biogenic amines and physiological membranes in drug therapy, pt B, pp. 173-258. Dekker, New York.
40. Homykiewicz, O. (1971b) In: McDowell, F. H. & Markham, A. H., ed. Recent advances in Parkinson’s disease, pp. 33-65. Davis, Philadelphia, Pa.
41. Homykiewicz, O. (1972a) In: Lajtha, A., ed. Handbook of neurochemistry. Vol. 7: Pathological chemistry of the nervous system, pp. 465-501. Plenum Press, New York & London.
42. Homykiewicz, O.(1972b) In: Kopin, I. J., ed. Neurotransmitters, pp. 390-412. (Res. Publs Ass. Res. nerv. ment. Dis., vol. 50) Williams & Wilkins, Baltimore, Md.
43. Homykiewicz, O. (1972c) In: Siegfried, J., ed. Parkinson’s disease, rigidity, akinesia, behavior, vol. 1, pp. 128-149. (Proceedings of the Fourth International Symposium on Parkinson’s Disease, Zürich, 1971) Huber, Bern.
44. Kebabian, J. W., Petzold, G. L. & Greengard, P. (1972) Proc. natn. Acad. Sci. U.S.A. 69, 2145-2149.
45. Lloyd, K. G. (1972) Biogenic amines and related enzymes in the human and animal brain. (Thesis for Ph.D. degree) University of Toronto.
46. Lloyd, K. [G.] & Homykiewicz, O. (1970) Science, N. Y. 170, 1212-1213.
47. Lloyd, K. G. & Homykiewicz, O. (1972) J. Neurochem. 19, 1549- 1559.
48. McLennan, H. (1965) Experientia, 21, 725-726.
49. Mones, R. J. (1972) Mt Sinai J. Med. 39, 197-201.
50. Neff, N. H. & Costa, E. (1967) In: Garattini, S. & Dukes, M. N. G., ed. Antidepressant drugs, pp. 28-34. (Proceedings of the First International Symposium, Milan, April 25-27, 1966) (International Congress Series no. 122) Excerpta Medica Foundation, Amsterdam.
51. Poirier, L. J. & Sourkes, T. L. (1965) Brain, 88, 181-192.
52. Portig, P. J. & Vogt, M. (1969) J. Physiol., Lond. 204, 687- 715.
53. Riddell, D. & Szerb, J. C. (1971) J. Neurochem. 18, 989-1006.
54. Tate, S. S., Sweet, R., McDowell, F. H. & Meister, A. (1971) Proc. natn. Acad. Sci. U.S.A. 68, 2121-2123.
55. Ungerstedt, U. (1971) In: Malmfors, T. & Thoenen, H., ed. Hydroxydopamine and catecholamine neurons, pp. 101-127. North-Holland, Amsterdam & London.
56. Ungerstedt, U., Butcher, L. L., Butcher, S. G., Andén, N. E. & Fuxe, K. (1969) Brain Res. 14, 461-471.
57. York, D. H. (1970) Brain Res. 20, 233-249.